MedTrace Logo

Evaluating Technologies for Point-of-Care Blood Collections by Patients

NCT06507566 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2026-01-23

Study results available
· View outcomes & findings →

Summary

A study evaluating technologies for point-of-care use in clinical trials.

Conditions

  • Healthy

Interventions

DEVICE

Tasso+™

The Tasso+™ blood collection kit is a collection device (called the Tasso+™) and a capillary collection tube that allows for the storage of the blood in a liquid format in different matrices.

Sponsors & Collaborators

  • ICON Government and Public Health Solutions, Inc

    collaborator UNKNOWN

  • Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies

    collaborator OTHER_GOV

  • Alachua Government Services, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-29
Primary Completion
2025-04-04
Completion
2025-04-04
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06507566 on ClinicalTrials.gov